ActivControl® Technology for slowing myopia progression in age appropriate children.

Special contact lens technology for children that corrects their vision while slowing myopia progression in children (aged 8-12 at the initiation of treatment) by 59%, on average.*1

explaining myopia

For illustrative purposes only 

Is your child struggling to see the board at school or the television at home? Are objects in the distance blurry? If so, one potential cause is nearsightedness—or what eye care professionals call myopia. When your child has myopia, their eyes are growing too long, and light focuses in front of the retina. This blurs their vision, so they need spectacles or contact lenses to see clearly.

Did you know? 8 in 10 eye care professionals agree that they worry about their pediatric patients having significant eye health issues, such as retinal detachment or glaucoma, later in their lives due to the progression of their myopia.2 And that risk multiplies as a child’s prescriptions get stronger.3

Thanks to ActivControl® Technology, nearsighted children  (aged 8-12 at the initiation of treatment) can now enjoy freedom from glasses when wearing their contact lenses while potentially slowing down the progression of their myopia  at the same time.1


childhood myopia

Specifically designed to reduce the progression of myopia (nearsightedness) 1; helping to control the axial length and refractive error increases of the eye in age appropriate children which can help to reduce the risk of myopia-related vision complications later in life4

childhood freedom from glasses

Gives age-appropriate children freedom from glasses when wearing their contact lenses1

daily replacement schedule

Easy for children to use.1 Convenient daily disposable contact lenses—no need to clean or store them

ActivControl® Technology at work

Where you can find this technology:

Talk to your eye care professional about the benefits for your age-appropriate child of the Brilliant Futures™ Myopia Management Program with MiSight® 1 day contact lenses.


* Compared with a single-vision one-day lens over a three-year period.


1. Chamberlain P, et al. “A 3-year Randomized Clinical Trial of MiSight® Lenses for Myopia Control.” Optom Vis Sci 2019;96:556–567.

2. CVI data on file 2019. Global survey by Decision Analyst with 402 ECPs in UK, Canada, Germany, Spain, Hong Kong, Australia/NZ. 82% agreed on a 1-10 point scale (top 4-box).

3. Flitcroft DI. “The complex interactions of retinal, optical, and environmental factors in myopia.” Prog Retin Eye Res 2012;31(6):622-660.

4. Tideman JW, Snabel MC, Tedja MS, et al. “Association of axial length with risk of uncorrectable visual impairment for Europeans with myopia.” JAMA Ophthalmol 2016;134:1355-1363.